HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to halt devastating lung damage in young transplant patients
Disease control OngoingThis study is testing if adding the drug ruxolitinib to standard steroid treatment can reverse early signs of lung damage in children and adults who have had a stem cell transplant. The goal is to stop the progression to a severe, often fatal lung condition called bronchiolitis o…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo aims to make leukemia transplants safer and more effective
Disease control OngoingThis study is testing a specific combination of two drugs (fludarabine and treosulfan) given to patients before they receive a stem cell transplant for acute myeloid leukemia (AML). The goal is to see if this drug regimen helps control the leukemia better while causing fewer seve…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC